Guideline-concordant treatment is associated with improved survival among women with non-endometrioid endometrial cancer.
CONCLUSIONS: While more than half of women with non-endometrioid EC did not receive GCT, no difference in GCT receipt by race/ethnicity was observed. When received, GCT was associated with improved survival in almost all racial groups. Interventions to improve GCT adherence may improve survival for most women with non-endometrioid EC.
PMID: 32217002 [PubMed - as supplied by publisher]
Source: Gynecologic Oncology - Category: Cancer & Oncology Authors: Dholakia J, Llamocca E, Quick A, Salani R, Felix AS Tags: Gynecol Oncol Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Databases & Libraries | Endometrial Cancer | Study | Women